Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stryker Corp (SYK)

Stryker Corp (SYK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 146,015,120
  • Shares Outstanding, K 381,689
  • Annual Sales, $ 22,595 M
  • Annual Income, $ 2,993 M
  • EBIT $ 5,168 M
  • EBITDA $ 6,218 M
  • 60-Month Beta 0.91
  • Price/Sales 6.44
  • Price/Cash Flow 25.26
  • Price/Book 6.95

Options Overview Details

View History
  • Implied Volatility 22.45% ( +0.47%)
  • Historical Volatility 15.57%
  • IV Percentile 54%
  • IV Rank 19.41%
  • IV High 47.93% on 04/08/25
  • IV Low 16.31% on 06/12/24
  • Put/Call Vol Ratio 0.04
  • Today's Volume 1,456
  • Volume Avg (30-Day) 1,071
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 33,153
  • Open Int (30-Day) 32,923

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 3.06
  • Number of Estimates 13
  • High Estimate 3.16
  • Low Estimate 3.00
  • Prior Year 2.81
  • Growth Rate Est. (year over year) +8.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
371.27 +3.19%
on 05/23/25
394.92 -2.99%
on 05/19/25
+1.74 (+0.46%)
since 05/05/25
3-Month
329.16 +16.39%
on 04/07/25
394.92 -2.99%
on 05/19/25
-12.59 (-3.18%)
since 03/05/25
52-Week
314.93 +21.65%
on 08/05/24
406.19 -5.68%
on 01/28/25
+37.11 (+10.73%)
since 06/05/24

Most Recent Stories

More News
Is Stryker Stock Underperforming the Nasdaq?

Although Stryker has slightly underperformed the Nasdaq over the past year, its fundamentals have remained strong, and analysts remain strongly bullish on the stock’s prospects.

$NASX : 19,298.45 (-0.83%)
SYK : 383.10 (+0.14%)
BSX : 102.83 (+0.39%)
Stryker Stock: Analyst Estimates & Ratings

Stryker has outperformed the broader market over the past year, Wall Street analysts remain highly bullish about the stock's prospects.

XLV : 133.11 (-0.14%)
SYK : 383.10 (+0.14%)
$SPX : 5,939.30 (-0.53%)
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks

These longtime Fundsmith holdings are still great buys today.

MSFT : 467.68 (+0.82%)
META : 684.62 (-0.48%)
SYK : 383.10 (+0.14%)
BRK.A : 732,953.19 (-0.66%)
BRK.B : 488.74 (-0.46%)
ORCL : 171.14 (+1.81%)
Stryker declares an $0.84 per share quarterly dividend

SYK : 383.10 (+0.14%)
2 S&P 500 Stocks Worth Investigating and 1 to Avoid

2 S&P 500 Stocks Worth Investigating and 1 to Avoid

SYK : 383.10 (+0.14%)
BSX : 102.83 (+0.39%)
VTRS : 8.46 (-1.51%)
Stryker: Q1 Earnings Snapshot

Stryker: Q1 Earnings Snapshot

SYK : 383.10 (+0.14%)
Stryker reports first quarter 2025 operating results

SYK : 383.10 (+0.14%)
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues. Inflationary...

SYK : 383.10 (+0.14%)
BDX : 171.03 (+0.05%)
BAX : 30.15 (+0.60%)
CAH : 154.12 (+0.03%)
DXCM : 85.74 (+0.15%)
ISRG vs. SYK: Which Robotic-Device Innovator Is a Better Buy?

As robotic-assisted surgery becomes a cornerstone of modern healthcare, two medtech giants — Intuitive Surgical ISRG and Stryker SYK — are leading the charge. Intuitive, the pioneer behind the da...

SYK : 383.10 (+0.14%)
ISRG : 558.06 (+0.02%)
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference

SYK : 383.10 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products...

See More

Key Turning Points

3rd Resistance Point 387.52
2nd Resistance Point 386.06
1st Resistance Point 384.58
Last Price 383.10
1st Support Level 381.64
2nd Support Level 380.18
3rd Support Level 378.70

See More

52-Week High 406.19
Last Price 383.10
Fibonacci 61.8% 371.33
Fibonacci 50% 360.56
Fibonacci 38.2% 349.79
52-Week Low 314.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »